SOX2 and cancer: Given that SOX2 itself acts as a pioneer transcription factor throughout development, we determined that increased levels of this protein further reprogram the chromatin landscape of cancer cells, binding at multiple regulatory regions, increasing chromatin accessibility, and driving subsequent up-regulation of genes associated with epithelium development.